BODITECH MED INC.

Other languages Boditech Med Inc.

Equities

A206640

KR7206640005

End-of-day quote Korea S.E. Other stock markets 03:30:00 05/06/2024 am IST			5-day change	1st Jan Change
17,500 ^KRW	-1.30%		-0.91%	-14.63%

21/02	4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.	CI
2023	Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid	31/23/31
Boditech Med Inc. and SphingoTec GmbH Enters into Non-Exclusive Royalty-Bearing License Agreement	15/22/15
Boditech Med Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.	29/22/29
Boditech Med Inc. authorizes a Buyback Plan.	29/22/29
Novo Integrated Sciences, Boditech Med Sign Memorandum of Understanding for Distribution of Diagnostic Technologies	29/22/29
Novo Integrated Sciences, Inc. Signs Memorandum of Understanding with Boditech Med to Market and Distribute in North America	29/22/29
Boditech Med Announces the Formation of a U.S. Based Advisory Board and its First Member, Zachariah P. Zachariah, M.D	24/22/24
Boditech Med Partners with Novo Integrated Sciences, Inc. to Market and Distribute Lower-Cost, Rapid Testing in North America	23/22/23
Boditech Med to Expand to U.S., North America	18/22/18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer